Treatment implications of posterior fossa ependymoma subgroups
Abstract Posterior fossa ependymoma comprises two distinct molecular entities, ependymoma_posterior fossa A (EPN_PFA) and ependymoma_posterior fossa B (EPN_PFB), with differentiable gene expression profiles. As yet, the response of the two entities to treatment is unclear. To determine the relations...
Main Authors: | Vijay Ramaswamy, Michael D. Taylor |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-11-01
|
Series: | Chinese Journal of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40880-016-0155-6 |
Similar Items
-
Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features – a retrospective analysis of the HIT ependymoma trial cohort
by: Stephanie T. Jünger, et al.
Published: (2019-11-01) -
Identification of key methylation differentially expressed genes in posterior fossa ependymoma based on epigenomic and transcriptome analysis
by: Guanyi Wang, et al.
Published: (2021-04-01) -
CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma
by: Roberta Antonelli, et al.
Published: (2020-07-01) -
Ependymoma Pediatric Brain Tumor Protein Fingerprinting by Integrated Mass Spectrometry Platforms: A Pilot Investigation
by: Diana Valeria Rossetti, et al.
Published: (2020-03-01) -
Posterior Fossa Syndrome
by: Serhan Kupeli
Published: (2014-08-01)